Literature DB >> 32348737

Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation.

Ming-Jie Jiang1, Dian-Na Gu2, Juan-Juan Dai3, Qian Huang4, Ling Tian5.   

Abstract

Accelerated tumor repopulation following chemoradiation is often observed in the clinic, but the underlying mechanisms remain unclear. In recent years, dying cells caused by chemoradiation have attracted much attention, and they may manifest diverse forms of cell death and release complex factors and thus orchestrate tumor repopulation cascades. Dying cells potentiate the survival of residual living tumor cells, remodel the tumor microenvironment, boost cell proliferation, and accelerate cancer cell metastasis. Moreover, dying cells also mediate the side effects of chemoradiation. These findings suggest more caution when weighing the benefits of cytotoxic therapy and the need to accordingly develop new strategies for cancer treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer microenvironment; cell death; chemoradiation; dying cell; tumor repopulation

Mesh:

Substances:

Year:  2020        PMID: 32348737     DOI: 10.1016/j.trecan.2020.01.018

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  14 in total

Review 1.  Towards targeting of shared mechanisms of cancer metastasis and therapy resistance.

Authors:  Felix Weiss; Douglas Lauffenburger; Peter Friedl
Journal:  Nat Rev Cancer       Date:  2022-01-10       Impact factor: 60.716

2.  Combined Action of Hyper-Harmonized Hydroxylated Fullerene Water Complex and Hyperpolarized Light Leads to Melanoma Cell Reprogramming In Vitro.

Authors:  Milica Markelić; Dijana Drača; Tamara Krajnović; Zorana Jović; Milica Vuksanović; Djuro Koruga; Sanja Mijatović; Danijela Maksimović-Ivanić
Journal:  Nanomaterials (Basel)       Date:  2022-04-13       Impact factor: 5.719

3.  Analysis of exosomal circRNAs upon irradiation in pancreatic cancer cell repopulation.

Authors:  Yi-Yun Chen; Ming-Jie Jiang; Ling Tian
Journal:  BMC Med Genomics       Date:  2020-07-29       Impact factor: 3.063

4.  Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation.

Authors:  Yucui Zhao; Yanwei Song; Ruyi Zhao; Minghui Zhao; Qian Huang
Journal:  Front Oncol       Date:  2020-11-20       Impact factor: 6.244

Review 5.  Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.

Authors:  Christophe Bounaix Morand du Puch; Mathieu Vanderstraete; Stéphanie Giraud; Christophe Lautrette; Niki Christou; Muriel Mathonnet
Journal:  Theranostics       Date:  2021-09-21       Impact factor: 11.556

6.  A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects.

Authors:  Ho Jin Lee; Hye-Young Min; Young-Sik Yong; Jihyae Ann; Cong Truong Nguyen; Minh Thanh La; Seung Yeob Hyun; Huong Thuy Le; Hyewon Kim; Hyukjin Kwon; Gibeom Nam; Hyun-Ju Park; Jeewoo Lee; Ho-Young Lee
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

7.  Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer.

Authors:  Ekaterina S Kuligina; Fedor V Moiseyenko; Albina S Zhabina; Sergey A Belukhin; Tatiana A Laidus; Aleksandr S Martianov; Kirill A Zagorodnev; Tatyana N Sokolova; Svetlana A Chuinyshena; Maxim M Kholmatov; Elizaveta V Artemieva; Ekaterina O Stepanova; Tatiana N Shuginova; Nikita M Volkov; Grigoriy A Yanus; Evgeny N Imyanitov
Journal:  Int J Clin Oncol       Date:  2022-02-16       Impact factor: 3.850

Review 8.  New Insights into Therapy-Induced Progression of Cancer.

Authors:  Polina V Shnaider; Olga M Ivanova; Irina K Malyants; Ksenia S Anufrieva; Ilya A Semenov; Marat S Pavlyukov; Maria A Lagarkova; Vadim M Govorun; Victoria O Shender
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

9.  Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1.

Authors:  Seung Hyeon Kim; Su-Jung Kim; Jeongmin Park; Yeonsoo Joe; So Eui Lee; Soma Saeidi; Xiancai Zhong; Seong Hoon Kim; Sin-Aye Park; Hye-Kyung Na; Hun Taeg Chung; Young-Joon Surh
Journal:  Antioxidants (Basel)       Date:  2021-03-16

Review 10.  177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements.

Authors:  Jianpeng Cao; Yue Chen; Mei Hu; Wei Zhang
Journal:  Ann Nucl Med       Date:  2021-06-27       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.